(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013
18:04

Meta Introduces Palm-Sized Device to Use Muse AI
19:04

Disney+ Price to Jump 13% to $21.49 Per Month
22:21